Metformin (Matee (850 mg)) is an oral antidiabetic agent, prescribed for type 2 diabetes. It helps control blood sugar levels. The information provided on this page is intended to serve as a ...

In the largest investigation into the issue to date, metformin did not improve survival of patients with high-risk, operable breast cancer when added to standard adjuvant treatments. These findings ...

March 22, 2012 — Long-term treatment with metformin is safe for preventing or delaying the development of type 2 diabetes, according to an article published in the April issue of Diabetes Care. New ...

Preclinical studies in endometrial cancer (EC) show that metformin reduces cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term presurgical metformin reduces ...

Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...

For women with recurrent or late-stage endometrial cancer, including metformin as part of a standard chemotherapy regimen offered no additional benefit, a phase II/III study indicated. In the trial of ...

Patients undergoing glucocorticoid treatment are at risk of developing metabolic adverse effects, such as the metabolic syndrome. Preclinical studies have suggested that metformin can prevent these ...